Ronald M. Buijsen
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Loss of astrocytic markers and impaired metabolic function in spinocerebellar ataxia type 7 patient-derived neural cultures.
Journal: Neurobiology of disease
Published: April 24, 2026
Selective silencing of expanded CAG repeats: Chemically modified siRNA advances RNA-based therapies for polyglutamine diseases.
Journal: Molecular therapy. Nucleic acids
Published: March 05, 2026
Generation of 4 human induced pluripotent stem cell lines (LUMCi070-A, -B, -C, and -D) from a patient with ischemic cerebral small vessel disease.
Journal: Stem cell research
Published: February 19, 2026
Impedance-based phenotypic profiling of metabotropic glutamate receptor ligand responses in SCA1 human iPSC-derived neuronal cultures.
Journal: Neurobiology of disease
Published: December 17, 2025
Generation of an isogenic human induced pluripotent stem cell line for spinocerebellar ataxia type 1.
Journal: Stem cell research
Published: December 12, 2025
Targeting rare splicing defects: Antisense oligonucleotides offer a therapeutic strategy in FRDA.
Journal: Molecular therapy. Nucleic acids
Published: October 27, 2025
A Novel APP p.V742L variant in a patient with ischemic small vessel disease enhances FE65 signalling.
Journal: Neurobiology of disease
Published: October 07, 2025
Determining off-target effects of splice-switching antisense oligonucleotides using short read RNAseq in neuronally differentiated human induced pluripotent stem cells.
Journal: Human molecular genetics
Published: July 02, 2025
Calcium-Enhanced Medium-Based Delivery of Splice Modulating Antisense Oligonucleotides in 2D and 3D hiPSC-Derived Neuronal Models.
Journal: Biomedicines
Published: July 08, 2024
Training and peer-group coaching for pairs of researchers and patient representatives to support continuous two-way learning.
Journal: Research involvement and engagement
Published: May 08, 2024
Generation of human induced pluripotent stem cell lines (LUMCi051-A,B and LUMCi052-A,B,C) of two patients with Spinocerebellar ataxia type 7.
Journal: Stem cell research
Published: April 17, 2024
Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice.
Journal: Neurobiology of disease
Published: September 08, 2023
Last Updated: 09/26/2026